Arterial Blood Gas (ABG) Analysis
Arterial blood gas (ABG) analysis is a diagnostic test that measures the partial pressures of oxygen and carbon dioxide in arterial blood, along with pH and bicarbonate levels, to assess how effectively the lungs and kidneys are maintaining acid-base balance and gas exchange. The test provides data unavailable through non-invasive monitoring alone, making it foundational in critical care, emergency medicine, and pulmonary evaluation. Understanding ABG interpretation is central to managing respiratory failure, ventilator settings, and acid-base disorders across a wide range of clinical conditions covered throughout Pulmonary Authority.
Definition and Scope
An arterial blood gas panel measures five primary parameters from a sample drawn directly from an artery — most commonly the radial artery at the wrist, though femoral and brachial sites are also used. The five core values reported are:
- pH — reflects overall acid-base status; normal arterial range is 7.35–7.45 (AARC Clinical Practice Guidelines)
- PaO₂ (partial pressure of arterial oxygen) — normal range approximately 80–100 mmHg at sea level
- PaCO₂ (partial pressure of arterial carbon dioxide) — normal range 35–45 mmHg
- HCO₃⁻ (bicarbonate) — calculated value reflecting metabolic component; normal range 22–26 mEq/L
- SaO₂ (oxygen saturation of hemoglobin) — normal ≥95%
Some panels also include lactate, hemoglobin, and electrolyte values depending on analyzer configuration. The American Association for Respiratory Care (AARC) publishes Clinical Practice Guidelines for blood gas analysis and hemoximetry that define acceptable pre-analytical, analytical, and post-analytical procedures for clinical laboratories performing this test.
The regulatory context for pulmonary medicine includes Clinical Laboratory Improvement Amendments (CLIA) oversight of blood gas laboratories under 42 CFR Part 493, administered by the Centers for Medicare and Medicaid Services (CMS). Blood gas analyzers used in point-of-care settings are subject to FDA device classification as well as CLIA proficiency testing requirements.
How It Works
Specimen collection begins with the modified Allen test, a two-step occlusion maneuver used to confirm collateral ulnar circulation before radial artery puncture. The AARC guideline specifies this confirmation step as a pre-procedure requirement. A heparinized syringe is used to collect 1–3 mL of arterial blood; samples must be analyzed within 30 minutes at room temperature or stored on ice to prevent cellular metabolism from artificially altering gas values.
Analysis occurs in a blood gas analyzer that uses electrochemical sensors:
- A pH electrode (glass membrane) measures hydrogen ion activity
- A PaCO₂ electrode (Severinghaus electrode) measures CO₂ tension
- A PaO₂ electrode (Clark electrode) uses an oxygen-permeable membrane and polarographic current to measure dissolved oxygen
Bicarbonate is not directly measured; it is calculated using the Henderson-Hasselbalch equation: pH = 6.1 + log([HCO₃⁻] / [0.0307 × PaCO₂]).
Interpretation follows a systematic four-step framework endorsed in standard respiratory therapy training programs aligned with NBRC (National Board for Respiratory Care) credentialing content outlines:
- Assess pH — acidemic (<7.35) or alkalemic (>7.45)
- Identify the primary disorder — respiratory (PaCO₂-driven) or metabolic (HCO₃⁻-driven)
- Evaluate compensation — is the opposing system responding proportionally?
- Assess oxygenation separately — PaO₂ and A-a gradient
The alveolar-arterial (A-a) gradient compares expected alveolar oxygen tension to measured arterial oxygen, helping distinguish ventilation-perfusion mismatch from pure hypoventilation.
Common Scenarios
ABG analysis is ordered across a range of acute and chronic pulmonary and metabolic conditions. The test is routinely applied in the following clinical contexts:
Respiratory failure evaluation — ABG distinguishes Type 1 (hypoxemic) from Type 2 (hypercapnic) respiratory failure. Type 1 is characterized by PaO₂ <60 mmHg with normal or low PaCO₂, indicating gas exchange failure without ventilatory pump failure. Type 2 includes elevated PaCO₂ >45 mmHg, indicating inadequate alveolar ventilation — a pattern common in advanced COPD, neuromuscular disease, or severe pulmonary fibrosis.
Ventilator management — In mechanically ventilated patients, ABGs guide adjustments to tidal volume, respiratory rate, PEEP (positive end-expiratory pressure), and FiO₂. The ARDSNet protocol, published in the New England Journal of Medicine (2000, Volume 342), established lung-protective ventilation targets using PaO₂ and plateau pressure thresholds derived from serial ABG monitoring.
Acid-base disorders — ABG combined with serum electrolytes identifies metabolic acidosis (e.g., diabetic ketoacidosis, lactic acidosis) or metabolic alkalosis (e.g., prolonged vomiting, diuretic use) and distinguishes them from respiratory causes. The anion gap calculation supplements ABG interpretation in metabolic acidosis.
Titrating oxygen therapy — In patients receiving supplemental oxygen, including those using home oxygen therapy, ABG confirms whether PaO₂ targets are being met — a standard used in CMS coverage criteria for home oxygen under the Local Coverage Determinations administered by Medicare Administrative Contractors.
Pulmonary embolism workup — ABG may show hypoxemia, hypocapnia, and an elevated A-a gradient in pulmonary embolism, though the finding is neither sensitive nor specific enough to confirm or exclude the diagnosis independently.
Decision Boundaries
ABG is not equivalent to pulse oximetry. Pulse oximetry measures SpO₂ non-invasively but cannot detect hypercapnia, acid-base disturbances, or abnormal hemoglobin variants such as carboxyhemoglobin or methemoglobin. In carbon monoxide poisoning, SpO₂ reads falsely normal while ABG with co-oximetry reveals true oxygen saturation and carboxyhemoglobin percentage.
Venous blood gas (VBG) is sometimes substituted for ABG in lower-acuity settings. Central venous pH correlates reasonably with arterial pH (difference typically <0.04 units), but venous PO₂ does not reflect arterial oxygenation and cannot be used to assess respiratory failure.
Contraindications to radial artery puncture include a negative Allen test result (absent collateral circulation), local infection at the puncture site, and the presence of an arteriovenous fistula in that limb. Complications are uncommon but include hematoma, arterial spasm, and — rarely — thrombosis. The AARC Clinical Practice Guideline on sampling from arterial lines and puncture sites outlines minimum competency and procedural standards for respiratory therapists and clinical staff performing the procedure.
For the pulmonary function tests comparison: PFTs measure airflow mechanics and lung volumes under controlled conditions, while ABG captures real-time gas exchange and acid-base status at a single physiological moment. The two tests address different clinical questions and are frequently ordered together in the evaluation of complex pulmonary disease.
References
- American Association for Respiratory Care (AARC) — Clinical Practice Guidelines
- National Board for Respiratory Care (NBRC)
- Centers for Medicare and Medicaid Services (CMS) — CLIA Program (42 CFR Part 493)
- U.S. Food and Drug Administration (FDA) — In Vitro Diagnostics
- ARDSNet — Ventilation with Lower Tidal Volumes, NEJM 2000, Vol. 342
- CMS Medicare Coverage — Home Oxygen Local Coverage Determinations
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)